Emerita Torres

Emerita Torres serves as a key procurement professional within the W40M MRC0 West agency of the Department of the Army, responsible for securing critical medical readiness capabilities that support field-deployable, high-acuity care. Her work centers on acquiring in-vitro diagnostic substances, surgical instruments, sterilization systems, and blood management solutions essential to operational medical sovereignty. She manages the full lifecycle of contracts—from market research and solicitation to award and performance monitoring—ensuring alignment with Army medical doctrine and the Defense Health Agency’s readiness priorities. Her acquisitions directly enable combat medics and field hospitals to deliver life-saving care under austere conditions. Torres maintains strategic relationships with leading medical technology vendors including Roche Diagnostics Corporation, Abbott Molecular Inc., Cardinal Health 414, LLC, Surgical Neuromonitoring Associates, Inc., and Premier Shockwave, Inc. These partnerships reflect a focus on high-reliability, FDA-regulated medical devices and diagnostic platforms requiring rigorous validation and supply chain resilience. Her contracting approach emphasizes performance-based specifications, technical compliance, and long-term service agreements, fostering collaborative vendor engagement to ensure mission-critical product availability in expeditionary environments. While the majority of her acquisitions are unrestricted, she consistently prioritizes small business participation, with nearly 31% of awards designated as total small business set-asides under FAR 19.5, and an additional 3% allocated to 8(a) competed contracts. This reflects a deliberate effort to broaden the supplier base while maintaining technical rigor, balancing innovation from emerging medical tech firms with the proven reliability of established manufacturers. Her procurement focus is concentrated in NAICS 811210 for electronic and precision equipment repair, 339112 for surgical instrument manufacturing, and 339113 for surgical appliance and supplies, with notable activity in in-vitro diagnostic substance manufacturing (325413). She specializes in procuring complex, regulated medical technologies requiring compliance with ISO 13485 and FDA 21 CFR Part 820, demonstrating deep technical fluency in diagnostic, surgical, and point-of-care medical systems.